Benoît Trottier

Statistics

Publications

Citations

5.2K

H-Index

Active since

2003

Affiliations

Centre Hospitalier de l’Université de Montréal(Current)

Université de Montréal

McGill University Health Centre

McGill University

University of Toronto

Benoît Trottier is an author at Centre Hospitalier de l’Université de Montréal specializing in antiretroviral therapy, infectious diseases, and antiviral therapy.

ORCID

Publications per year

2003–2023

Publications

Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America

Jacob Lalezari, Keith Henry, Mary O’Hearn et al. · New England Journal of Medicine · 2003 · 915 citations · Full text

Life Sciences, Pharmacokinetics, Pharmacotherapy +16

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

Paul E. Sax, David A. Wohl, Michael T. Yin et al. · The Lancet · 2015 · 598 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study

Jean‐Michel Molina, Isabelle Charreau, Bruno Spire et al. · The Lancet HIV · 2017 · 472 citations · Full text

Public Health, Infectious Disease Control, Preventive Medicine +16

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial

Adriano Lazzarin, Thomas Campbell, Bonaventura Clotet et al. · The Lancet · 2007 · 392 citations

Medicine, Infectious Diseases, Pharmacology +12

Subgroup Analyses of Maraviroc in Previously Treated R5 HIV-1 Infection

Gerd Fätkenheuer, Mark Nelson, Adriano Lazzarin et al. · New England Journal of Medicine · 2008 · 361 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

1–5 of 62